Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Assets (2018 - 2025)

Cue Biopharma (CUE) has disclosed Return on Assets for 8 consecutive years, with 0.13% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 5.0% to 0.13% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.14% for FY2025, 1.0% up from the prior year.
  • Return on Assets hit 0.13% in Q4 2025 for Cue Biopharma, down from 0.12% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.12% in Q3 2025 to a low of 1.0% in Q3 2024.
  • Historically, Return on Assets has averaged 0.53% across 5 years, with a median of 0.55% in 2022.
  • Biggest five-year swings in Return on Assets: decreased -29bps in 2024 and later surged 88bps in 2025.
  • Year by year, Return on Assets stood at 0.54% in 2021, then dropped by -17bps to 0.63% in 2022, then fell by -20bps to 0.76% in 2023, then soared by 76bps to 0.18% in 2024, then rose by 29bps to 0.13% in 2025.
  • Business Quant data shows Return on Assets for CUE at 0.13% in Q4 2025, 0.12% in Q3 2025, and 0.17% in Q2 2025.